Allarity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALLR and other ETFs, options, and stocks.About ALLR
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States.
CEOThomas H. Jensen
CEOThomas H. Jensen
Employees7
Employees7
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2021
Founded2021
Employees7
Employees7
ALLR Key Statistics
Market cap16.91M
Market cap16.91M
Price-Earnings ratio-0.67
Price-Earnings ratio-0.67
Dividend yield—
Dividend yield—
Average volume164.07K
Average volume164.07K
High today$1.10
High today$1.10
Low today$1.04
Low today$1.04
Open price$1.10
Open price$1.10
Volume59.28K
Volume59.28K
52 Week high$2.35
52 Week high$2.35
52 Week low$0.6138
52 Week low$0.6138
Stock Snapshot
As of today, Allarity Therapeutics(ALLR) shares are valued at $1.05. The company's market cap stands at 16.91M, with a P/E ratio of -0.67.
On 2025-12-27, Allarity Therapeutics(ALLR) stock moved within a range of $1.04 to $1.10. With shares now at $1.05, the stock is trading +1.0% above its intraday low and -4.5% below the session's peak.
Trading activity shows a volume of 59.28K, compared to an average daily volume of 164.07K.
Over the past 52 weeks, Allarity Therapeutics(ALLR) stock has traded between a high of $2.35 and a low of $0.61.
Over the past 52 weeks, Allarity Therapeutics(ALLR) stock has traded between a high of $2.35 and a low of $0.61.
People also own
Based on the portfolios of people who own ALLR. This list is generated using Robinhood data, and it’s not a recommendation.